Table 1 Demographic and clinical characteristics of the ESAS-ma (2013) and ESAS-r b (2017) patient samples
Characteristic | ESAS-ma (n = 184) | ESAS-r b (n = 156) | P = value |
|---|---|---|---|
Age, years | |||
Mean (SD) | 64.6 (12.7) | 66.7 (10.7) | p = .10 |
Range | 29–93 | 32–91 | |
Sex, % (n) | p > .99 | ||
Male | 43(76) | 42 (65) | |
Female | 59 (108) | 58 (91) | |
Cohabitation status, % (n) | p = .80 | ||
Married/cohabitant | 41 (76) | 57 (88) | |
Primary diagnosis % (n) | p = .48 | ||
Gastrointestinal cancer | 23 (41) | 30 (47) | |
Lung cancer | 23 (41) | 17 (26) | |
Breast cancer | 13 (23) | 11 (17) | |
Gynecologic cancer | 10 (19) | 10 (15) | |
Genital cancer male | 8 (15) | 7 (11) | |
Brain Cancer | 3 (6) | 1 (2) | |
Other cancer | 21 (39) | 24 (38) | |
Metastases | p = .78 | ||
Yes, % (n) | 84 (155) | 86 (134) | |
Number of prescribed medications | p = .48 | ||
Mean (SD) | 8.5 (3.6) | 8.2 (3.2) | |
Range | 1–19 | 2–17 | |
Type of medical treatment, % (n) | |||
Opioids | 83 (153) | 78 (122) | p = .31 |
Non-opioids pain medication | 57 (105) | 51 (79) | p = .28 |
Corticosteroids | 61 (112) | 49 (77) | p = .43 |
Anti-depressants | 25 (46) | 21 (33) | p = .48 |
Benzodiazepines | 47 (85) | 37 (58) | p = .12 |